act.org,actprofile.org,act.org,actstudent.org,act.alertline.com,services.actstudent.org,career4.successfactors.com,engage.act.org,discoveractaspire.org,qc.vantage.com,myworkkeys.act.org,twitter.com,facebook.com,youtube.com,plus.google.com,linkedin.com,preview.act.org,workreadycommunities.org,pearson.com,instagram.com,actaspire.org,run2.careerready101.com,run2.keytrain.com,leadershipblog.act.org
Losartan can be administered once or twice daily at total daily doses of 25 to 100 mg. If the antihypertensive effect measured at trough using once-aday dosing is inadequate, a twice-a-day regimen at the same total daily dose or an increase in dose may give a more satisfactory response.
In 4 clinical trials involving over 1000 patients on various doses (10-150 mg) of losartan potassium and over 300 patients given placebo, the adverse events that occurred in â¥2% of patients treated with COZAAR and more commonly than placebo were: dizziness (3% vs. 2%), upper respiratory infection (8% vs. 7%), nasal congestion (2% vs. 1%), and back pain (2% vs. 1%).